Drug details

Onglyza (saxagliptin tablets)

type of Antidiabetics, Biguanides/Dipeptyl Peptidase-IV Inhibitors

Onglyza (saxagliptin) is an orally-active inhibitor of the DPP4 enzyme used either alone or with other medications, and with a proper diet and exercise program, to control high blood sugar. Onglyza is used in people with type 2 (non-insulin-dependent) diabetes.

The drug is often used to treat Diabetes .

This drug may have the following side effects:

• cough,
• sore throat,
• runny or stuffy nose,
• headache, or
• stomach pain.

The following drugs are related to Onglyza, either as a replacement or used together:

• Precose (acarbose)
• Amaryl Tablets (glimepiride)
• Avandamet (rosiglitazone maleate and metformin hcl)
• Avandia (rosiglitazone maleate)
• Brenzavvy (bexagliflozin tablets)
• Byetta (exenatide injection)
• Qternmet XR (dapagliflozin, saxagliptin, and metformin hydrochloride)
• Zegalogue (dasiglucagon injection)
• Glucotrol (glipizide)
• Glucovance (glyburide and metformin)
• Micronase (glyburide)
• Glynase PresTab (micronized glyburide tablets)
• Glyset (miglitol)
• NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart (rdna origin))
• Lantus (insulin glargine [rdna origin] injection)
• Victoza (liraglutide [rdna] injection)
• Starlix Tablet (nateglinide)
• Symlin (pramlintide acetate injection)
• Prandin (repaglinide)